Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

INTRODUCTION: Kidney transplant recipients (KTRs) are at an increased risk of hospitalisation and death from COVID-19. Vaccination against SARS-CoV-2 is our primary risk mitigation strategy, yet vaccine effectiveness in KTRs is suboptimal. Strategies to enhance vaccine efficacy are therefore require...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Julian, Tunbridge, Matthew, Perkins, Griffith B, Salehi, Tania, Ying, Tracey, Wu, Huiling, Coates, P Toby, Chadban, Steven J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716412/
https://www.ncbi.nlm.nih.gov/pubmed/36456021
http://dx.doi.org/10.1136/bmjopen-2022-062747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716412/
https://www.ncbi.nlm.nih.gov/pubmed/36456021
http://dx.doi.org/10.1136/bmjopen-2022-062747

Ejemplares similares